Related Experiment Video

Updated: Apr 17, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

A new horizon for glucose monitoring

Klemen Dovč1, Nataša Bratina, Tadej Battelino

  • 1Department of Endocrinology, Diabetes and Metabolism, UMC, University Children's Hospital, Ljubljana, Slovenia.

Hormone Research in Paediatrics
|February 10, 2015
PubMed

Insights

Continuous glucose monitoring (CGM) offers valuable real-time data for pediatric type 1 diabetes management. Despite barriers like cost, CGM shows promise for improving glycemic control and enabling closed-loop insulin delivery systems.

Area of Science:

  • Pediatric Endocrinology
  • Biomedical Engineering
  • Diabetes Technology

Background:

  • Glycemic control in pediatric type 1 diabetes remains challenging, with many children not meeting glycated hemoglobin A1c targets.
  • Traditional self-monitoring of blood glucose (SMBG) provides limited trend information.
  • Continuous glucose monitoring (CGM) devices offer real-time glucose data and trend analysis.

Purpose of the Study:

  • To review evidence from randomized controlled trials on CGM use in pediatric populations.
  • To explore barriers to wider CGM adoption.
  • To provide insights into the broader utilization of CGM, including integration with automated insulin delivery systems.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) involving pediatric participants.
  • Analysis of data on glycemic control, patient decision-making, and clinical understanding.
  • Assessment of barriers to CGM implementation, including cost.

Main Results:

  • CGM provides comprehensive glucose trend data, aiding patient and clinician decision-making.
  • Evidence suggests CGM can contribute to improved glycemic control in children with type 1 diabetes.
  • Cost remains a significant barrier to widespread CGM adoption globally.

Conclusions:

  • CGM is a valuable tool for managing pediatric type 1 diabetes, offering insights beyond traditional SMBG.
  • Addressing cost barriers is crucial for expanding CGM access.
  • Future directions include integrating CGM with closed-loop insulin delivery systems for enhanced diabetes management.

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

1.3K
Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

8.8K

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.5K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.1K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
2
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
37.7K